Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc. | Financial_Report.xls |
| 10-Q - UNITED STATES SECURITIES AND EXCHANGE COMMISSION - Q Therapeutics, Inc. | qholdings10q18312011_10q.htm |
| EX-31.2 - EXHIBIT 31.2 - Q Therapeutics, Inc. | exhibit31_ex31z2.htm |
| EX-32.1 - EXHIBIT 32.1 - Q Therapeutics, Inc. | exhibit321_ex32z1.htm |
| EX-31.1 - EXHIBIT 31.1 - Q Therapeutics, Inc. | exhibit311_ex31z1.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Grace 2, Inc. (the Company) on Form 10-Q for the quarterly period ended August 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Steven J. Borst, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: December 2, 2011 |
| By: /s/ STEVEN J. BORST |
|
| Name: Steven J. Borst Title: Vice President, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |